Medical Care
Global Viral and Non-viral Vector Market Research Report 2025
- Jan 17, 26
- ID: 678747
- Pages: 84
- Figures: 85
- Views: 5
This report aims to provide a comprehensive presentation of the global market for Viral and Non-viral Vector, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral and Non-viral Vector.
The Viral and Non-viral Vector market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Viral and Non-viral Vector market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Viral and Non-viral Vector companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Oxford BioMedica
Lonza
GENEWIZ
Revvity
VectorBuilder
OBIO Technology
Takara Bio
GenScript Biotech
Gene Chem
Geno Meditech
PackGene Biotech
VIROVEK
Segment by Type
AAV
Lentiviruses
Retroviruses
Adenoviruses
DNA Plasmids
Others
Segment by Application
Pharmaceutical and Biopharmaceutical Companies
Academics and Research Institutes
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Viral and Non-viral Vector company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Viral and Non-viral Vector market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Viral and Non-viral Vector market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Viral and Non-viral Vector companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Oxford BioMedica
Lonza
GENEWIZ
Revvity
VectorBuilder
OBIO Technology
Takara Bio
GenScript Biotech
Gene Chem
Geno Meditech
PackGene Biotech
VIROVEK
Segment by Type
AAV
Lentiviruses
Retroviruses
Adenoviruses
DNA Plasmids
Others
Segment by Application
Pharmaceutical and Biopharmaceutical Companies
Academics and Research Institutes
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Viral and Non-viral Vector company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral and Non-viral Vector Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 AAV
1.2.3 Lentiviruses
1.2.4 Retroviruses
1.2.5 Adenoviruses
1.2.6 DNA Plasmids
1.2.7 Others
1.3 Market by Application
1.3.1 Global Viral and Non-viral Vector Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical and Biopharmaceutical Companies
1.3.3 Academics and Research Institutes
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral and Non-viral Vector Market Perspective (2020-2031)
2.2 Global Viral and Non-viral Vector Growth Trends by Region
2.2.1 Global Viral and Non-viral Vector Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Viral and Non-viral Vector Historic Market Size by Region (2020-2025)
2.2.3 Viral and Non-viral Vector Forecasted Market Size by Region (2026-2031)
2.3 Viral and Non-viral Vector Market Dynamics
2.3.1 Viral and Non-viral Vector Industry Trends
2.3.2 Viral and Non-viral Vector Market Drivers
2.3.3 Viral and Non-viral Vector Market Challenges
2.3.4 Viral and Non-viral Vector Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral and Non-viral Vector Players by Revenue
3.1.1 Global Top Viral and Non-viral Vector Players by Revenue (2020-2025)
3.1.2 Global Viral and Non-viral Vector Revenue Market Share by Players (2020-2025)
3.2 Global Top Viral and Non-viral Vector Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Viral and Non-viral Vector Revenue
3.4 Global Viral and Non-viral Vector Market Concentration Ratio
3.4.1 Global Viral and Non-viral Vector Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral and Non-viral Vector Revenue in 2024
3.5 Global Key Players of Viral and Non-viral Vector Head office and Area Served
3.6 Global Key Players of Viral and Non-viral Vector, Product and Application
3.7 Global Key Players of Viral and Non-viral Vector, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral and Non-viral Vector Breakdown Data by Type
4.1 Global Viral and Non-viral Vector Historic Market Size by Type (2020-2025)
4.2 Global Viral and Non-viral Vector Forecasted Market Size by Type (2026-2031)
5 Viral and Non-viral Vector Breakdown Data by Application
5.1 Global Viral and Non-viral Vector Historic Market Size by Application (2020-2025)
5.2 Global Viral and Non-viral Vector Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Viral and Non-viral Vector Market Size (2020-2031)
6.2 North America Viral and Non-viral Vector Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Viral and Non-viral Vector Market Size by Country (2020-2025)
6.4 North America Viral and Non-viral Vector Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral and Non-viral Vector Market Size (2020-2031)
7.2 Europe Viral and Non-viral Vector Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Viral and Non-viral Vector Market Size by Country (2020-2025)
7.4 Europe Viral and Non-viral Vector Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral and Non-viral Vector Market Size (2020-2031)
8.2 Asia-Pacific Viral and Non-viral Vector Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Viral and Non-viral Vector Market Size by Region (2020-2025)
8.4 Asia-Pacific Viral and Non-viral Vector Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Viral and Non-viral Vector Market Size (2020-2031)
9.2 Latin America Viral and Non-viral Vector Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Viral and Non-viral Vector Market Size by Country (2020-2025)
9.4 Latin America Viral and Non-viral Vector Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral and Non-viral Vector Market Size (2020-2031)
10.2 Middle East & Africa Viral and Non-viral Vector Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Viral and Non-viral Vector Market Size by Country (2020-2025)
10.4 Middle East & Africa Viral and Non-viral Vector Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Viral and Non-viral Vector Introduction
11.1.4 Thermo Fisher Scientific Revenue in Viral and Non-viral Vector Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Oxford BioMedica
11.2.1 Oxford BioMedica Company Details
11.2.2 Oxford BioMedica Business Overview
11.2.3 Oxford BioMedica Viral and Non-viral Vector Introduction
11.2.4 Oxford BioMedica Revenue in Viral and Non-viral Vector Business (2020-2025)
11.2.5 Oxford BioMedica Recent Development
11.3 Lonza
11.3.1 Lonza Company Details
11.3.2 Lonza Business Overview
11.3.3 Lonza Viral and Non-viral Vector Introduction
11.3.4 Lonza Revenue in Viral and Non-viral Vector Business (2020-2025)
11.3.5 Lonza Recent Development
11.4 GENEWIZ
11.4.1 GENEWIZ Company Details
11.4.2 GENEWIZ Business Overview
11.4.3 GENEWIZ Viral and Non-viral Vector Introduction
11.4.4 GENEWIZ Revenue in Viral and Non-viral Vector Business (2020-2025)
11.4.5 GENEWIZ Recent Development
11.5 Revvity
11.5.1 Revvity Company Details
11.5.2 Revvity Business Overview
11.5.3 Revvity Viral and Non-viral Vector Introduction
11.5.4 Revvity Revenue in Viral and Non-viral Vector Business (2020-2025)
11.5.5 Revvity Recent Development
11.6 VectorBuilder
11.6.1 VectorBuilder Company Details
11.6.2 VectorBuilder Business Overview
11.6.3 VectorBuilder Viral and Non-viral Vector Introduction
11.6.4 VectorBuilder Revenue in Viral and Non-viral Vector Business (2020-2025)
11.6.5 VectorBuilder Recent Development
11.7 OBIO Technology
11.7.1 OBIO Technology Company Details
11.7.2 OBIO Technology Business Overview
11.7.3 OBIO Technology Viral and Non-viral Vector Introduction
11.7.4 OBIO Technology Revenue in Viral and Non-viral Vector Business (2020-2025)
11.7.5 OBIO Technology Recent Development
11.8 Takara Bio
11.8.1 Takara Bio Company Details
11.8.2 Takara Bio Business Overview
11.8.3 Takara Bio Viral and Non-viral Vector Introduction
11.8.4 Takara Bio Revenue in Viral and Non-viral Vector Business (2020-2025)
11.8.5 Takara Bio Recent Development
11.9 GenScript Biotech
11.9.1 GenScript Biotech Company Details
11.9.2 GenScript Biotech Business Overview
11.9.3 GenScript Biotech Viral and Non-viral Vector Introduction
11.9.4 GenScript Biotech Revenue in Viral and Non-viral Vector Business (2020-2025)
11.9.5 GenScript Biotech Recent Development
11.10 Gene Chem
11.10.1 Gene Chem Company Details
11.10.2 Gene Chem Business Overview
11.10.3 Gene Chem Viral and Non-viral Vector Introduction
11.10.4 Gene Chem Revenue in Viral and Non-viral Vector Business (2020-2025)
11.10.5 Gene Chem Recent Development
11.11 Geno Meditech
11.11.1 Geno Meditech Company Details
11.11.2 Geno Meditech Business Overview
11.11.3 Geno Meditech Viral and Non-viral Vector Introduction
11.11.4 Geno Meditech Revenue in Viral and Non-viral Vector Business (2020-2025)
11.11.5 Geno Meditech Recent Development
11.12 PackGene Biotech
11.12.1 PackGene Biotech Company Details
11.12.2 PackGene Biotech Business Overview
11.12.3 PackGene Biotech Viral and Non-viral Vector Introduction
11.12.4 PackGene Biotech Revenue in Viral and Non-viral Vector Business (2020-2025)
11.12.5 PackGene Biotech Recent Development
11.13 VIROVEK
11.13.1 VIROVEK Company Details
11.13.2 VIROVEK Business Overview
11.13.3 VIROVEK Viral and Non-viral Vector Introduction
11.13.4 VIROVEK Revenue in Viral and Non-viral Vector Business (2020-2025)
11.13.5 VIROVEK Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral and Non-viral Vector Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 AAV
1.2.3 Lentiviruses
1.2.4 Retroviruses
1.2.5 Adenoviruses
1.2.6 DNA Plasmids
1.2.7 Others
1.3 Market by Application
1.3.1 Global Viral and Non-viral Vector Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical and Biopharmaceutical Companies
1.3.3 Academics and Research Institutes
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral and Non-viral Vector Market Perspective (2020-2031)
2.2 Global Viral and Non-viral Vector Growth Trends by Region
2.2.1 Global Viral and Non-viral Vector Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Viral and Non-viral Vector Historic Market Size by Region (2020-2025)
2.2.3 Viral and Non-viral Vector Forecasted Market Size by Region (2026-2031)
2.3 Viral and Non-viral Vector Market Dynamics
2.3.1 Viral and Non-viral Vector Industry Trends
2.3.2 Viral and Non-viral Vector Market Drivers
2.3.3 Viral and Non-viral Vector Market Challenges
2.3.4 Viral and Non-viral Vector Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral and Non-viral Vector Players by Revenue
3.1.1 Global Top Viral and Non-viral Vector Players by Revenue (2020-2025)
3.1.2 Global Viral and Non-viral Vector Revenue Market Share by Players (2020-2025)
3.2 Global Top Viral and Non-viral Vector Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Viral and Non-viral Vector Revenue
3.4 Global Viral and Non-viral Vector Market Concentration Ratio
3.4.1 Global Viral and Non-viral Vector Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral and Non-viral Vector Revenue in 2024
3.5 Global Key Players of Viral and Non-viral Vector Head office and Area Served
3.6 Global Key Players of Viral and Non-viral Vector, Product and Application
3.7 Global Key Players of Viral and Non-viral Vector, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral and Non-viral Vector Breakdown Data by Type
4.1 Global Viral and Non-viral Vector Historic Market Size by Type (2020-2025)
4.2 Global Viral and Non-viral Vector Forecasted Market Size by Type (2026-2031)
5 Viral and Non-viral Vector Breakdown Data by Application
5.1 Global Viral and Non-viral Vector Historic Market Size by Application (2020-2025)
5.2 Global Viral and Non-viral Vector Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Viral and Non-viral Vector Market Size (2020-2031)
6.2 North America Viral and Non-viral Vector Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Viral and Non-viral Vector Market Size by Country (2020-2025)
6.4 North America Viral and Non-viral Vector Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral and Non-viral Vector Market Size (2020-2031)
7.2 Europe Viral and Non-viral Vector Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Viral and Non-viral Vector Market Size by Country (2020-2025)
7.4 Europe Viral and Non-viral Vector Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral and Non-viral Vector Market Size (2020-2031)
8.2 Asia-Pacific Viral and Non-viral Vector Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Viral and Non-viral Vector Market Size by Region (2020-2025)
8.4 Asia-Pacific Viral and Non-viral Vector Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Viral and Non-viral Vector Market Size (2020-2031)
9.2 Latin America Viral and Non-viral Vector Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Viral and Non-viral Vector Market Size by Country (2020-2025)
9.4 Latin America Viral and Non-viral Vector Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral and Non-viral Vector Market Size (2020-2031)
10.2 Middle East & Africa Viral and Non-viral Vector Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Viral and Non-viral Vector Market Size by Country (2020-2025)
10.4 Middle East & Africa Viral and Non-viral Vector Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Viral and Non-viral Vector Introduction
11.1.4 Thermo Fisher Scientific Revenue in Viral and Non-viral Vector Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Oxford BioMedica
11.2.1 Oxford BioMedica Company Details
11.2.2 Oxford BioMedica Business Overview
11.2.3 Oxford BioMedica Viral and Non-viral Vector Introduction
11.2.4 Oxford BioMedica Revenue in Viral and Non-viral Vector Business (2020-2025)
11.2.5 Oxford BioMedica Recent Development
11.3 Lonza
11.3.1 Lonza Company Details
11.3.2 Lonza Business Overview
11.3.3 Lonza Viral and Non-viral Vector Introduction
11.3.4 Lonza Revenue in Viral and Non-viral Vector Business (2020-2025)
11.3.5 Lonza Recent Development
11.4 GENEWIZ
11.4.1 GENEWIZ Company Details
11.4.2 GENEWIZ Business Overview
11.4.3 GENEWIZ Viral and Non-viral Vector Introduction
11.4.4 GENEWIZ Revenue in Viral and Non-viral Vector Business (2020-2025)
11.4.5 GENEWIZ Recent Development
11.5 Revvity
11.5.1 Revvity Company Details
11.5.2 Revvity Business Overview
11.5.3 Revvity Viral and Non-viral Vector Introduction
11.5.4 Revvity Revenue in Viral and Non-viral Vector Business (2020-2025)
11.5.5 Revvity Recent Development
11.6 VectorBuilder
11.6.1 VectorBuilder Company Details
11.6.2 VectorBuilder Business Overview
11.6.3 VectorBuilder Viral and Non-viral Vector Introduction
11.6.4 VectorBuilder Revenue in Viral and Non-viral Vector Business (2020-2025)
11.6.5 VectorBuilder Recent Development
11.7 OBIO Technology
11.7.1 OBIO Technology Company Details
11.7.2 OBIO Technology Business Overview
11.7.3 OBIO Technology Viral and Non-viral Vector Introduction
11.7.4 OBIO Technology Revenue in Viral and Non-viral Vector Business (2020-2025)
11.7.5 OBIO Technology Recent Development
11.8 Takara Bio
11.8.1 Takara Bio Company Details
11.8.2 Takara Bio Business Overview
11.8.3 Takara Bio Viral and Non-viral Vector Introduction
11.8.4 Takara Bio Revenue in Viral and Non-viral Vector Business (2020-2025)
11.8.5 Takara Bio Recent Development
11.9 GenScript Biotech
11.9.1 GenScript Biotech Company Details
11.9.2 GenScript Biotech Business Overview
11.9.3 GenScript Biotech Viral and Non-viral Vector Introduction
11.9.4 GenScript Biotech Revenue in Viral and Non-viral Vector Business (2020-2025)
11.9.5 GenScript Biotech Recent Development
11.10 Gene Chem
11.10.1 Gene Chem Company Details
11.10.2 Gene Chem Business Overview
11.10.3 Gene Chem Viral and Non-viral Vector Introduction
11.10.4 Gene Chem Revenue in Viral and Non-viral Vector Business (2020-2025)
11.10.5 Gene Chem Recent Development
11.11 Geno Meditech
11.11.1 Geno Meditech Company Details
11.11.2 Geno Meditech Business Overview
11.11.3 Geno Meditech Viral and Non-viral Vector Introduction
11.11.4 Geno Meditech Revenue in Viral and Non-viral Vector Business (2020-2025)
11.11.5 Geno Meditech Recent Development
11.12 PackGene Biotech
11.12.1 PackGene Biotech Company Details
11.12.2 PackGene Biotech Business Overview
11.12.3 PackGene Biotech Viral and Non-viral Vector Introduction
11.12.4 PackGene Biotech Revenue in Viral and Non-viral Vector Business (2020-2025)
11.12.5 PackGene Biotech Recent Development
11.13 VIROVEK
11.13.1 VIROVEK Company Details
11.13.2 VIROVEK Business Overview
11.13.3 VIROVEK Viral and Non-viral Vector Introduction
11.13.4 VIROVEK Revenue in Viral and Non-viral Vector Business (2020-2025)
11.13.5 VIROVEK Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Viral and Non-viral Vector Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of AAV
Table 3. Key Players of Lentiviruses
Table 4. Key Players of Retroviruses
Table 5. Key Players of Adenoviruses
Table 6. Key Players of DNA Plasmids
Table 7. Key Players of Others
Table 8. Global Viral and Non-viral Vector Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Viral and Non-viral Vector Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Viral and Non-viral Vector Market Size by Region (2020-2025) & (US$ Million)
Table 11. Global Viral and Non-viral Vector Market Share by Region (2020-2025)
Table 12. Global Viral and Non-viral Vector Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 13. Global Viral and Non-viral Vector Market Share by Region (2026-2031)
Table 14. Viral and Non-viral Vector Market Trends
Table 15. Viral and Non-viral Vector Market Drivers
Table 16. Viral and Non-viral Vector Market Challenges
Table 17. Viral and Non-viral Vector Market Restraints
Table 18. Global Viral and Non-viral Vector Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Viral and Non-viral Vector Market Share by Players (2020-2025)
Table 20. Global Top Viral and Non-viral Vector Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral and Non-viral Vector as of 2024)
Table 21. Ranking of Global Top Viral and Non-viral Vector Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Viral and Non-viral Vector Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Viral and Non-viral Vector, Headquarters and Area Served
Table 24. Global Key Players of Viral and Non-viral Vector, Product and Application
Table 25. Global Key Players of Viral and Non-viral Vector, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Viral and Non-viral Vector Market Size by Type (2020-2025) & (US$ Million)
Table 28. Global Viral and Non-viral Vector Revenue Market Share by Type (2020-2025)
Table 29. Global Viral and Non-viral Vector Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 30. Global Viral and Non-viral Vector Revenue Market Share by Type (2026-2031)
Table 31. Global Viral and Non-viral Vector Market Size by Application (2020-2025) & (US$ Million)
Table 32. Global Viral and Non-viral Vector Revenue Market Share by Application (2020-2025)
Table 33. Global Viral and Non-viral Vector Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 34. Global Viral and Non-viral Vector Revenue Market Share by Application (2026-2031)
Table 35. North America Viral and Non-viral Vector Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. North America Viral and Non-viral Vector Market Size by Country (2020-2025) & (US$ Million)
Table 37. North America Viral and Non-viral Vector Market Size by Country (2026-2031) & (US$ Million)
Table 38. Europe Viral and Non-viral Vector Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Viral and Non-viral Vector Market Size by Country (2020-2025) & (US$ Million)
Table 40. Europe Viral and Non-viral Vector Market Size by Country (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Viral and Non-viral Vector Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia-Pacific Viral and Non-viral Vector Market Size by Region (2020-2025) & (US$ Million)
Table 43. Asia-Pacific Viral and Non-viral Vector Market Size by Region (2026-2031) & (US$ Million)
Table 44. Latin America Viral and Non-viral Vector Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Latin America Viral and Non-viral Vector Market Size by Country (2020-2025) & (US$ Million)
Table 46. Latin America Viral and Non-viral Vector Market Size by Country (2026-2031) & (US$ Million)
Table 47. Middle East & Africa Viral and Non-viral Vector Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Middle East & Africa Viral and Non-viral Vector Market Size by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Viral and Non-viral Vector Market Size by Country (2026-2031) & (US$ Million)
Table 50. Thermo Fisher Scientific Company Details
Table 51. Thermo Fisher Scientific Business Overview
Table 52. Thermo Fisher Scientific Viral and Non-viral Vector Product
Table 53. Thermo Fisher Scientific Revenue in Viral and Non-viral Vector Business (2020-2025) & (US$ Million)
Table 54. Thermo Fisher Scientific Recent Development
Table 55. Oxford BioMedica Company Details
Table 56. Oxford BioMedica Business Overview
Table 57. Oxford BioMedica Viral and Non-viral Vector Product
Table 58. Oxford BioMedica Revenue in Viral and Non-viral Vector Business (2020-2025) & (US$ Million)
Table 59. Oxford BioMedica Recent Development
Table 60. Lonza Company Details
Table 61. Lonza Business Overview
Table 62. Lonza Viral and Non-viral Vector Product
Table 63. Lonza Revenue in Viral and Non-viral Vector Business (2020-2025) & (US$ Million)
Table 64. Lonza Recent Development
Table 65. GENEWIZ Company Details
Table 66. GENEWIZ Business Overview
Table 67. GENEWIZ Viral and Non-viral Vector Product
Table 68. GENEWIZ Revenue in Viral and Non-viral Vector Business (2020-2025) & (US$ Million)
Table 69. GENEWIZ Recent Development
Table 70. Revvity Company Details
Table 71. Revvity Business Overview
Table 72. Revvity Viral and Non-viral Vector Product
Table 73. Revvity Revenue in Viral and Non-viral Vector Business (2020-2025) & (US$ Million)
Table 74. Revvity Recent Development
Table 75. VectorBuilder Company Details
Table 76. VectorBuilder Business Overview
Table 77. VectorBuilder Viral and Non-viral Vector Product
Table 78. VectorBuilder Revenue in Viral and Non-viral Vector Business (2020-2025) & (US$ Million)
Table 79. VectorBuilder Recent Development
Table 80. OBIO Technology Company Details
Table 81. OBIO Technology Business Overview
Table 82. OBIO Technology Viral and Non-viral Vector Product
Table 83. OBIO Technology Revenue in Viral and Non-viral Vector Business (2020-2025) & (US$ Million)
Table 84. OBIO Technology Recent Development
Table 85. Takara Bio Company Details
Table 86. Takara Bio Business Overview
Table 87. Takara Bio Viral and Non-viral Vector Product
Table 88. Takara Bio Revenue in Viral and Non-viral Vector Business (2020-2025) & (US$ Million)
Table 89. Takara Bio Recent Development
Table 90. GenScript Biotech Company Details
Table 91. GenScript Biotech Business Overview
Table 92. GenScript Biotech Viral and Non-viral Vector Product
Table 93. GenScript Biotech Revenue in Viral and Non-viral Vector Business (2020-2025) & (US$ Million)
Table 94. GenScript Biotech Recent Development
Table 95. Gene Chem Company Details
Table 96. Gene Chem Business Overview
Table 97. Gene Chem Viral and Non-viral Vector Product
Table 98. Gene Chem Revenue in Viral and Non-viral Vector Business (2020-2025) & (US$ Million)
Table 99. Gene Chem Recent Development
Table 100. Geno Meditech Company Details
Table 101. Geno Meditech Business Overview
Table 102. Geno Meditech Viral and Non-viral Vector Product
Table 103. Geno Meditech Revenue in Viral and Non-viral Vector Business (2020-2025) & (US$ Million)
Table 104. Geno Meditech Recent Development
Table 105. PackGene Biotech Company Details
Table 106. PackGene Biotech Business Overview
Table 107. PackGene Biotech Viral and Non-viral Vector Product
Table 108. PackGene Biotech Revenue in Viral and Non-viral Vector Business (2020-2025) & (US$ Million)
Table 109. PackGene Biotech Recent Development
Table 110. VIROVEK Company Details
Table 111. VIROVEK Business Overview
Table 112. VIROVEK Viral and Non-viral Vector Product
Table 113. VIROVEK Revenue in Viral and Non-viral Vector Business (2020-2025) & (US$ Million)
Table 114. VIROVEK Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
Table 118. Authors List of This Report
List of Figures
Figure 1. Viral and Non-viral Vector Picture
Figure 2. Global Viral and Non-viral Vector Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Viral and Non-viral Vector Market Share by Type: 2024 VS 2031
Figure 4. AAV Features
Figure 5. Lentiviruses Features
Figure 6. Retroviruses Features
Figure 7. Adenoviruses Features
Figure 8. DNA Plasmids Features
Figure 9. Others Features
Figure 10. Global Viral and Non-viral Vector Market Size by Application (2020-2031) & (US$ Million)
Figure 11. Global Viral and Non-viral Vector Market Share by Application: 2024 VS 2031
Figure 12. Pharmaceutical and Biopharmaceutical Companies Case Studies
Figure 13. Academics and Research Institutes Case Studies
Figure 14. Others Case Studies
Figure 15. Viral and Non-viral Vector Report Years Considered
Figure 16. Global Viral and Non-viral Vector Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Viral and Non-viral Vector Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Viral and Non-viral Vector Market Share by Region: 2024 VS 2031
Figure 19. Global Viral and Non-viral Vector Market Share by Players in 2024
Figure 20. Global Viral and Non-viral Vector Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. The Top 10 and 5 Players Market Share by Viral and Non-viral Vector Revenue in 2024
Figure 22. North America Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Viral and Non-viral Vector Market Share by Country (2020-2031)
Figure 24. United States Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Viral and Non-viral Vector Market Share by Country (2020-2031)
Figure 28. Germany Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Viral and Non-viral Vector Market Share by Region (2020-2031)
Figure 36. China Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Viral and Non-viral Vector Market Share by Country (2020-2031)
Figure 44. Mexico Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Viral and Non-viral Vector Market Share by Country (2020-2031)
Figure 48. Turkey Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Viral and Non-viral Vector Business (2020-2025)
Figure 52. Oxford BioMedica Revenue Growth Rate in Viral and Non-viral Vector Business (2020-2025)
Figure 53. Lonza Revenue Growth Rate in Viral and Non-viral Vector Business (2020-2025)
Figure 54. GENEWIZ Revenue Growth Rate in Viral and Non-viral Vector Business (2020-2025)
Figure 55. Revvity Revenue Growth Rate in Viral and Non-viral Vector Business (2020-2025)
Figure 56. VectorBuilder Revenue Growth Rate in Viral and Non-viral Vector Business (2020-2025)
Figure 57. OBIO Technology Revenue Growth Rate in Viral and Non-viral Vector Business (2020-2025)
Figure 58. Takara Bio Revenue Growth Rate in Viral and Non-viral Vector Business (2020-2025)
Figure 59. GenScript Biotech Revenue Growth Rate in Viral and Non-viral Vector Business (2020-2025)
Figure 60. Gene Chem Revenue Growth Rate in Viral and Non-viral Vector Business (2020-2025)
Figure 61. Geno Meditech Revenue Growth Rate in Viral and Non-viral Vector Business (2020-2025)
Figure 62. PackGene Biotech Revenue Growth Rate in Viral and Non-viral Vector Business (2020-2025)
Figure 63. VIROVEK Revenue Growth Rate in Viral and Non-viral Vector Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global Viral and Non-viral Vector Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of AAV
Table 3. Key Players of Lentiviruses
Table 4. Key Players of Retroviruses
Table 5. Key Players of Adenoviruses
Table 6. Key Players of DNA Plasmids
Table 7. Key Players of Others
Table 8. Global Viral and Non-viral Vector Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Viral and Non-viral Vector Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Viral and Non-viral Vector Market Size by Region (2020-2025) & (US$ Million)
Table 11. Global Viral and Non-viral Vector Market Share by Region (2020-2025)
Table 12. Global Viral and Non-viral Vector Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 13. Global Viral and Non-viral Vector Market Share by Region (2026-2031)
Table 14. Viral and Non-viral Vector Market Trends
Table 15. Viral and Non-viral Vector Market Drivers
Table 16. Viral and Non-viral Vector Market Challenges
Table 17. Viral and Non-viral Vector Market Restraints
Table 18. Global Viral and Non-viral Vector Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Viral and Non-viral Vector Market Share by Players (2020-2025)
Table 20. Global Top Viral and Non-viral Vector Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral and Non-viral Vector as of 2024)
Table 21. Ranking of Global Top Viral and Non-viral Vector Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Viral and Non-viral Vector Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Viral and Non-viral Vector, Headquarters and Area Served
Table 24. Global Key Players of Viral and Non-viral Vector, Product and Application
Table 25. Global Key Players of Viral and Non-viral Vector, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Viral and Non-viral Vector Market Size by Type (2020-2025) & (US$ Million)
Table 28. Global Viral and Non-viral Vector Revenue Market Share by Type (2020-2025)
Table 29. Global Viral and Non-viral Vector Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 30. Global Viral and Non-viral Vector Revenue Market Share by Type (2026-2031)
Table 31. Global Viral and Non-viral Vector Market Size by Application (2020-2025) & (US$ Million)
Table 32. Global Viral and Non-viral Vector Revenue Market Share by Application (2020-2025)
Table 33. Global Viral and Non-viral Vector Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 34. Global Viral and Non-viral Vector Revenue Market Share by Application (2026-2031)
Table 35. North America Viral and Non-viral Vector Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. North America Viral and Non-viral Vector Market Size by Country (2020-2025) & (US$ Million)
Table 37. North America Viral and Non-viral Vector Market Size by Country (2026-2031) & (US$ Million)
Table 38. Europe Viral and Non-viral Vector Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Viral and Non-viral Vector Market Size by Country (2020-2025) & (US$ Million)
Table 40. Europe Viral and Non-viral Vector Market Size by Country (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Viral and Non-viral Vector Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia-Pacific Viral and Non-viral Vector Market Size by Region (2020-2025) & (US$ Million)
Table 43. Asia-Pacific Viral and Non-viral Vector Market Size by Region (2026-2031) & (US$ Million)
Table 44. Latin America Viral and Non-viral Vector Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Latin America Viral and Non-viral Vector Market Size by Country (2020-2025) & (US$ Million)
Table 46. Latin America Viral and Non-viral Vector Market Size by Country (2026-2031) & (US$ Million)
Table 47. Middle East & Africa Viral and Non-viral Vector Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Middle East & Africa Viral and Non-viral Vector Market Size by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Viral and Non-viral Vector Market Size by Country (2026-2031) & (US$ Million)
Table 50. Thermo Fisher Scientific Company Details
Table 51. Thermo Fisher Scientific Business Overview
Table 52. Thermo Fisher Scientific Viral and Non-viral Vector Product
Table 53. Thermo Fisher Scientific Revenue in Viral and Non-viral Vector Business (2020-2025) & (US$ Million)
Table 54. Thermo Fisher Scientific Recent Development
Table 55. Oxford BioMedica Company Details
Table 56. Oxford BioMedica Business Overview
Table 57. Oxford BioMedica Viral and Non-viral Vector Product
Table 58. Oxford BioMedica Revenue in Viral and Non-viral Vector Business (2020-2025) & (US$ Million)
Table 59. Oxford BioMedica Recent Development
Table 60. Lonza Company Details
Table 61. Lonza Business Overview
Table 62. Lonza Viral and Non-viral Vector Product
Table 63. Lonza Revenue in Viral and Non-viral Vector Business (2020-2025) & (US$ Million)
Table 64. Lonza Recent Development
Table 65. GENEWIZ Company Details
Table 66. GENEWIZ Business Overview
Table 67. GENEWIZ Viral and Non-viral Vector Product
Table 68. GENEWIZ Revenue in Viral and Non-viral Vector Business (2020-2025) & (US$ Million)
Table 69. GENEWIZ Recent Development
Table 70. Revvity Company Details
Table 71. Revvity Business Overview
Table 72. Revvity Viral and Non-viral Vector Product
Table 73. Revvity Revenue in Viral and Non-viral Vector Business (2020-2025) & (US$ Million)
Table 74. Revvity Recent Development
Table 75. VectorBuilder Company Details
Table 76. VectorBuilder Business Overview
Table 77. VectorBuilder Viral and Non-viral Vector Product
Table 78. VectorBuilder Revenue in Viral and Non-viral Vector Business (2020-2025) & (US$ Million)
Table 79. VectorBuilder Recent Development
Table 80. OBIO Technology Company Details
Table 81. OBIO Technology Business Overview
Table 82. OBIO Technology Viral and Non-viral Vector Product
Table 83. OBIO Technology Revenue in Viral and Non-viral Vector Business (2020-2025) & (US$ Million)
Table 84. OBIO Technology Recent Development
Table 85. Takara Bio Company Details
Table 86. Takara Bio Business Overview
Table 87. Takara Bio Viral and Non-viral Vector Product
Table 88. Takara Bio Revenue in Viral and Non-viral Vector Business (2020-2025) & (US$ Million)
Table 89. Takara Bio Recent Development
Table 90. GenScript Biotech Company Details
Table 91. GenScript Biotech Business Overview
Table 92. GenScript Biotech Viral and Non-viral Vector Product
Table 93. GenScript Biotech Revenue in Viral and Non-viral Vector Business (2020-2025) & (US$ Million)
Table 94. GenScript Biotech Recent Development
Table 95. Gene Chem Company Details
Table 96. Gene Chem Business Overview
Table 97. Gene Chem Viral and Non-viral Vector Product
Table 98. Gene Chem Revenue in Viral and Non-viral Vector Business (2020-2025) & (US$ Million)
Table 99. Gene Chem Recent Development
Table 100. Geno Meditech Company Details
Table 101. Geno Meditech Business Overview
Table 102. Geno Meditech Viral and Non-viral Vector Product
Table 103. Geno Meditech Revenue in Viral and Non-viral Vector Business (2020-2025) & (US$ Million)
Table 104. Geno Meditech Recent Development
Table 105. PackGene Biotech Company Details
Table 106. PackGene Biotech Business Overview
Table 107. PackGene Biotech Viral and Non-viral Vector Product
Table 108. PackGene Biotech Revenue in Viral and Non-viral Vector Business (2020-2025) & (US$ Million)
Table 109. PackGene Biotech Recent Development
Table 110. VIROVEK Company Details
Table 111. VIROVEK Business Overview
Table 112. VIROVEK Viral and Non-viral Vector Product
Table 113. VIROVEK Revenue in Viral and Non-viral Vector Business (2020-2025) & (US$ Million)
Table 114. VIROVEK Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
Table 118. Authors List of This Report
List of Figures
Figure 1. Viral and Non-viral Vector Picture
Figure 2. Global Viral and Non-viral Vector Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Viral and Non-viral Vector Market Share by Type: 2024 VS 2031
Figure 4. AAV Features
Figure 5. Lentiviruses Features
Figure 6. Retroviruses Features
Figure 7. Adenoviruses Features
Figure 8. DNA Plasmids Features
Figure 9. Others Features
Figure 10. Global Viral and Non-viral Vector Market Size by Application (2020-2031) & (US$ Million)
Figure 11. Global Viral and Non-viral Vector Market Share by Application: 2024 VS 2031
Figure 12. Pharmaceutical and Biopharmaceutical Companies Case Studies
Figure 13. Academics and Research Institutes Case Studies
Figure 14. Others Case Studies
Figure 15. Viral and Non-viral Vector Report Years Considered
Figure 16. Global Viral and Non-viral Vector Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Viral and Non-viral Vector Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Viral and Non-viral Vector Market Share by Region: 2024 VS 2031
Figure 19. Global Viral and Non-viral Vector Market Share by Players in 2024
Figure 20. Global Viral and Non-viral Vector Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. The Top 10 and 5 Players Market Share by Viral and Non-viral Vector Revenue in 2024
Figure 22. North America Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Viral and Non-viral Vector Market Share by Country (2020-2031)
Figure 24. United States Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Viral and Non-viral Vector Market Share by Country (2020-2031)
Figure 28. Germany Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Viral and Non-viral Vector Market Share by Region (2020-2031)
Figure 36. China Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Viral and Non-viral Vector Market Share by Country (2020-2031)
Figure 44. Mexico Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Viral and Non-viral Vector Market Share by Country (2020-2031)
Figure 48. Turkey Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Viral and Non-viral Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Viral and Non-viral Vector Business (2020-2025)
Figure 52. Oxford BioMedica Revenue Growth Rate in Viral and Non-viral Vector Business (2020-2025)
Figure 53. Lonza Revenue Growth Rate in Viral and Non-viral Vector Business (2020-2025)
Figure 54. GENEWIZ Revenue Growth Rate in Viral and Non-viral Vector Business (2020-2025)
Figure 55. Revvity Revenue Growth Rate in Viral and Non-viral Vector Business (2020-2025)
Figure 56. VectorBuilder Revenue Growth Rate in Viral and Non-viral Vector Business (2020-2025)
Figure 57. OBIO Technology Revenue Growth Rate in Viral and Non-viral Vector Business (2020-2025)
Figure 58. Takara Bio Revenue Growth Rate in Viral and Non-viral Vector Business (2020-2025)
Figure 59. GenScript Biotech Revenue Growth Rate in Viral and Non-viral Vector Business (2020-2025)
Figure 60. Gene Chem Revenue Growth Rate in Viral and Non-viral Vector Business (2020-2025)
Figure 61. Geno Meditech Revenue Growth Rate in Viral and Non-viral Vector Business (2020-2025)
Figure 62. PackGene Biotech Revenue Growth Rate in Viral and Non-viral Vector Business (2020-2025)
Figure 63. VIROVEK Revenue Growth Rate in Viral and Non-viral Vector Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Ethylene Oxide (EO) Market Research Report 2026
Jan 17, 26
Global Stem Cells Cryopreservation Equipments Market Research Report 2026
Jan 17, 26
Global Selenium-enriched Yeast Market Research Report 2026
Jan 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232